Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale SVP & Chief Accounting Officer sold 724 shares at $13.58 ($9,832)
  2. 4 Open-market sale Director sold 15,000 shares at $16.27 ($244,050)
  3. 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $11.79 ($176,850)
  4. 4 Open-market sale SVP & Chief Medical Officer sold 556 shares at $11.92 ($6,628)
  5. 4 Open-market sale SVP & Chief Financial Officer sold 963 shares at $11.92 ($11,479)
  6. 4 Open-market sale President & CEO sold 2,147 shares at $11.92 ($25,592)
  7. 4 Open-market sale SVP & Chief Scientific Officer sold 390 shares at $11.92 ($4,649)
  8. 4 Open-market sale SVP & Chief Accounting Officer sold 716 shares at $11.92 ($8,535)
  9. 4 Open-market sale SVP & General Counsel sold 827 shares at $11.92 ($9,858)
  10. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 963 shares at $11.92 ($11,479)
  11. 4 Open-market sale SVP & General Counsel sold 11,666 shares at $11.49 ($134,042)
  12. 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $11.49 ($172,350)
  13. 4 Open-market sale President & CEO sold 66,666 shares at $11.49 ($765,992)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale SVP & Chief Accounting Officer sold 15,000 shares at $14.12 ($211,800)
  16. 4 Open-market sale President & CEO sold 66,667 shares at $14.12 ($941,338)
  17. 4 Open-market sale Director sold 15,000 shares at $14.51 ($217,650)
  18. 4 Insider Changes in Ownership
  19. 4/A Insider Changes in Ownership
  20. 4/A Insider Changes in Ownership

Page 26 of 49 · 970 filings